Tango Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-28.
Tango Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 28, 2025. The filing reports $15M sold. Its industry group is Pharmaceuticals. It names Barbara Weber (Executive Officer, Director), Daniella Beckman (Executive Officer), Adam Crystal (Executive Officer) (SEC Form D, October 28, 2025).
Is this your company?
Sell to companies like Tango Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Tango Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Tango Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Tango Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Tango Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Tango Therapeutics, Inc. →Get the full cited report on Tango Therapeutics, Inc.
What the filing shows about Tango Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Tango Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Tango Therapeutics, Inc.'s address as 201 Brookline Avenue, Suite 901, Boston, MA 02215.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Tango Therapeutics, Inc. See pricing
Tango Therapeutics, Inc. is a registered filer with the SEC (CIK 1819133) and has filed since 2023-08-24. 2 filings are on record, the latest on 2025-10-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Tango Therapeutics, Inc.'s Form D of 2025-10-28 names Barbara Weber, Daniella Beckman, Adam Crystal and 6 more as its officers, directors or promoters.
Its new offerings report $95.02M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week. The dot is this raise, $15M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Barbara Weber is named as Executive Officer and Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Daniella Beckman is named as Executive Officer on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Adam Crystal is named as Executive Officer on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Alexis Borisy is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Lesley Calhoun is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Malte Peters is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Mace Rothenberg is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
Kanishka Pothula is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
John Ketchum is named as Director on the Form D that Tango Therapeutics, Inc. filed with the SEC on 28 October 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-10-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Tango Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Tango Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tango Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Tango Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Tango Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Tango Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/tango-therapeutics-inc-form-d-25000001